Clinical trials
Completed Phase 1 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
452 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 6 |
| 2002 | 10 |
| 2003 | 9 |
| 2004 | 16 |
| 2005 | 18 |
| 2006 | 14 |
| 2007 | 16 |
| 2008 | 12 |
| 2009 | 20 |
| 2010 | 30 |
| 2011 | 18 |
| 2012 | 29 |
| 2013 | 22 |
| 2014 | 24 |
| 2015 | 23 |
| 2016 | 24 |
| 2017 | 26 |
| 2018 | 24 |
| 2019 | 19 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 452 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 48 |
| M.D. Anderson Cancer Center | 20 |
| Massachusetts General Hospital | 12 |
| Washington University School of Medicine | 10 |
| Memorial Sloan Kettering Cancer Center | 9 |
| Roswell Park Cancer Institute | 9 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 9 |
| Case Comprehensive Cancer Center | 7 |
| Hoffmann-La Roche | 7 |
| Novartis Pharmaceuticals | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 452 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 164 |
| Myelodysplastic Syndromes | 157 |
| Leukemia | 120 |
| Leukemia, Myelomonocytic, Chronic | 84 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 81 |
| Congenital Abnormalities | 73 |
| Blast Crisis | 70 |
| Lymphoma, Non-Hodgkin | 65 |
| Multiple Myeloma | 60 |
Trials
Showing 1 to 25 of 452. Each trial links to its page on Pharma Observatory.
352 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.